Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow

Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow

Atrial fibrillation (AF) is the most common heart rhythm disorder encountered in clinical practice. Each year, the number of patients with AF significantly increases. It is associated with an increase of life expectancy and frequency of cardiovascular pathologies. Treatment of AF remains one of the...

Full description

Bibliographic Details
Main Authors:	V. I. Podzolkov, A. I. Tarzimanova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2019-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atrial fibrillation treatment antiarrhythmic therapy
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2267

Similar Items

New possibilities of antiarrhythmic therapy of atrial fibrillation: A review
by: Aida I. Tarzimanova, et al.
Published: (2024-03-01)

Present and future of antiarrhythmic therapy for atrial fibrillation: A review
by: Aida I. Tarzimanova
Published: (2024-11-01)

Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS)
by: A. I. Tarzimanova, et al.
Published: (2021-09-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality?
by: V. I. Podzolkov, et al.
Published: (2019-03-01)

Safety issues of antiarrhythmic therapy for atrial fibrillation
by: I.I. Reznik, et al.
Published: (2024-01-01)

Reduced progression of atrial fibrillation in hypertensive patients with long-term treatment of propafenone
by: A. I Tarzimanova, et al.
Published: (2016-06-01)

Radiofrequency ablation and antiarrhythmic therapy in the treatment of patients with paroxysmal and persistent atrial fibrillation: clinical effects
by: M. G Bubnova, et al.
Published: (2015-09-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
by: Meng Geng, et al.
Published: (2020-11-01)

Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation
by: Takashi Komatsu
Published: (2012-06-01)

ASSOCIATION OF RS2200733 POLYMORPHISM WITH ANTIARRHYTHMIC THERAPY AND PROGRESSION OF ATRIAL FIBRILLATION IN THE UZBEK POPULATIO
by: R. D. Kurbanov, et al.
Published: (2020-12-01)

ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS
by: T. A. Rybakova, et al.
Published: (2018-08-01)

ATRIAL FIBRILLATION CATHETER ABLATION: YESTERDAY, TODAY, TOMORROW
by: D. S. Lebedev
Published: (2019-02-01)

ATRIAL FIBRILLATION CATHETER ABLATION: YESTERDAY, TODAY, TOMORROW
by: D. S. Lebedev
Published: (2019-02-01)

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation—Insights from the German Ablation Registry
by: Ruben Schleberger, et al.
Published: (2021-12-01)

Nationwide survey of catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF) – Report on antiarrhythmic drug therapy
by: Yuji Murakawa, MD, et al.
Published: (2014-10-01)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
by: Jonathan G. Tardos, et al.
Published: (2021-03-01)

Modern principles of atrial fibrillation therapy in patients with chronic heart failure
by: A. I. Tarzimanova, et al.
Published: (2005-06-01)

Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation
by: A. V. Tarasov, et al.
Published: (1970-01-01)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
by: Inseok Hwang, et al.
Published: (2021-05-01)

Pharmacological Treatment for Atrial Fibrillation
by: Kaoru Sugi, MD PhD, et al.
Published: (2005-01-01)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
by: Inseok Hwang, et al.
Published: (2022-12-01)

Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
by: Koichiro Kumagai, MD, et al.
Published: (2011-01-01)

ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION
by: Ju. P. Skirdenko, et al.
Published: (2016-05-01)

Effects of antiarrhythmic drug responsiveness and diagnosis‐to‐ablation time on outcomes after catheter ablation for persistent atrial fibrillation
by: Hong‐Ju Kim, et al.
Published: (2024-08-01)

Pharmacologic Therapy in the Elderly with Atrial Fibrillation
by: Shih-Huang Lee, et al.
Published: (2008-03-01)

A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation
by: Morten Lock Hansen, et al.
Published: (2024-07-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Sulimov, et al.
Published: (2016-01-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01)

Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis
by: Subhash Chander, et al.
Published: (2024-06-01)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
by: Christine Benn Christiansen, et al.
Published: (2010-03-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

Atrial fibrillation in the early postablation period: causes and treatment
by: S.Yu. Prorok
Published: (2023-11-01)

Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01)

CORRELATION BETWEEN HEART RHYTHM AND SYMPTOMS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AFTER CATHETER ABLATION AND ANTIARRHYTHMIC THERAPY BASED ON DATA OBTAINED FROM IMPLANTABLE CARDIAC MONITORS
by: A. A. Simonyan, et al.
Published: (2016-09-01)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
by: D. A. Tsaregorodtsev, et al.
Published: (2023-05-01)

Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter
by: E B Maĭkov, et al.
Published: (2015-01-01)

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
by: Marco Valerio Mariani, et al.
Published: (2022-10-01)